EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Thinking beyond the tablet: Acceptability of different HIV-PrEP modalities among GBMSM and gender-diverse individuals having sex with men in the UK

Dana Ogaz iD, Natasha Ratna, Hridhya Vijayan iD, Stephanie J Migchelsen iD, David Reid, Dolores Mullen iD, Dawn Phillips, Eleanor Bell, Tamara Djuretic, Will Nutland, Catherine H Mercer, Kate Folkard und 2 weitere

International Journal of STD & AIDS · 2026

DOI: 10.1177/09564624251369093 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of STD & AIDS, 2026. Verfasst von Dana Ogaz und 13 weiteren Autor:innen. Beteiligte Einrichtung: Blood Safety, Hepatitis, STI & HIV Division, UK Health Security Agency, London, UK. Hauptthemen laut MEDLINE: HIV Infections, Homosexuality, Male, Patient Acceptance of Health Care, Pre-Exposure Prophylaxis. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: University College London in partnership with the UK Health Security Agency.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

HIV-PrEP is a key component of HIV combination prevention and has been routinely available through oral formulations (i.e. oral tablets) across sexual health services (SHSs) in the UK since 2020. We used data from a large, online community survey to assess the acceptability and preference of different HIV-PrEP modalities among gay, bisexual, and other men who have sex with men (GBMSM) and gender-diverse individuals living in the UK.

Methods

Using data collected from the ‘Reducing inequalities in Sexual Health’ (RiiSH) survey, an online community survey of 1106 GBMSM and gender-diverse individuals having sex with men (November/December 2023), we performed a secondary analysis examining HIV-PrEP modality acceptability and preference (e.g. oral, long acting injectable, gel, or patch) (%) by HIV-PrEP history (never, in lookback period of last 3–4 months since survey completion). Where ≥2 modalities were indicated, participants were asked to specify a single preferred modality. Single choice options were assumed to be the preferred HIV-PrEP modality.

Results

Irrespective of HIV-PrEP history, long acting injectables were highly acceptable (>70%) and the preferred modality (58% [222/386] by those never having used HIV-PrEP, 73% [75/103] in those without HIV-PrEP use in the lookback, 74% [314/424] in those with HIV-PrEP use in the lookback).

Conclusions

We found high acceptability of the use of injectables, with general preference over oral tablets. If injectable HIV-PrEP becomes available at SHSs in England, these modalities could have positive impacts on HIV-PrEP delivery, use, and access.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HIV InfectionsHomosexuality, MalePatient Acceptance of Health CarePre-Exposure ProphylaxisSexual and Gender MinoritiesAnti-HIV AgentsHumansMaleUnited KingdomAdultTabletsMiddle AgedSurveys and QuestionnairesAdministration, OralYoung Adult

Stichwörter der Autor:innen

HIV (Human immunodeficiency virus)homosexualmenotherpreventionviral disease

Substanzen

TabletsAnti-HIV Agents

Autor:innen und Institutionen

  • Blood Safety, Hepatitis, STI & HIV Division, UK Health Security Agency, London, UK.
  • The National Institute for Health and Care Research Health Protection Research Unit in Blood Borne and Sexually Transmitted Infections at University College London in Partnership with the UK Health Security Agency, Lond…
  • Institute for Global Health, University College London, London, UK.
  • The Love Tank, London, UK.

ORCID-Profile: Dana Ogaz, Hridhya Vijayan, Stephanie J Migchelsen, Dolores Mullen, John Saunders, Hamish Mohammed

Förderung

  • University College London in partnership with the UK Health Security Agency

Zitieren

APA

Ogaz, D., Ratna, N., Vijayan, H., Migchelsen, S. J., Reid, D., Mullen, D., Phillips, D., Bell, E., Djuretic, T., Nutland, W., Mercer, C. H., Folkard, K., Saunders, J., & Mohammed, H. (2026). Thinking beyond the tablet: Acceptability of different HIV-PrEP modalities among GBMSM and gender-diverse individuals having sex with men in the UK. International Journal of STD & AIDS. https://doi.org/10.1177/09564624251369093

Vancouver

Ogaz D, Ratna N, Vijayan H, Migchelsen SJ, Reid D, Mullen D, et al. Thinking beyond the tablet: Acceptability of different HIV-PrEP modalities among GBMSM and gender-diverse individuals having sex with men in the UK. International Journal of STD & AIDS. 2026. doi:10.1177/09564624251369093

BibTeX
@article{Ogaz2026,
  author = {Ogaz, Dana and Ratna, Natasha and Vijayan, Hridhya and Migchelsen, Stephanie J and Reid, David and Mullen, Dolores and Phillips, Dawn and Bell, Eleanor and Djuretic, Tamara and Nutland, Will and Mercer, Catherine H and Folkard, Kate and Saunders, John and Mohammed, Hamish},
  title = {Thinking beyond the tablet: Acceptability of different HIV-PrEP modalities among GBMSM and gender-diverse individuals having sex with men in the UK},
  journal = {International Journal of STD & AIDS},
  year = {2026},
  doi = {10.1177/09564624251369093}
}
Kostenlos starten →